The Notch/Hes1 Pathway Sustains NF-κB Activation through CYLD Repression in T Cell Leukemia

被引:250
作者
Espinosa, Lluis [1 ]
Cathelin, Severine [2 ]
D'Altri, Teresa [1 ]
Trimarchi, Thomas [2 ]
Statnikov, Alexander [3 ,4 ,5 ]
Guiu, Jordi [1 ]
Rodilla, Veronica [1 ]
Ingles-Esteve, Julia [1 ]
Nomdedeu, Josep [6 ]
Bellosillo, Beatriz [7 ]
Besses, Carles [8 ]
Abdel-Wahab, Omar [9 ]
Kucine, Nicole [9 ,10 ]
Sun, Shao-Cong [11 ]
Song, Guangchan [12 ]
Mullighan, Charles C. [12 ]
Levine, Ross L. [9 ]
Rajewsky, Klaus [13 ,14 ]
Aifantis, Iannis [2 ]
Bigas, Anna [1 ]
机构
[1] Hosp del Mar, IMIM, Canc Res Program, Barcelona 08003, Spain
[2] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA
[3] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA
[4] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA
[5] NYU, Sch Med, Dept Med, New York, NY 10016 USA
[6] Hosp Santa Creu & Sant Pau, Dept Hematol, Barcelona 08025, Spain
[7] Hosp del Mar, Dept Pathol, Barcelona 08003, Spain
[8] Hosp del Mar, Dept Hematol, Barcelona 08003, Spain
[9] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA
[10] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10065 USA
[11] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA
[12] St Judes Res Hosp, Dept Pathol, Memphis, TN 38105 USA
[13] Harvard Univ, Sch Med, Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA
[14] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
DEUBIQUITINATING ENZYME CYLD; SIGNALING PATHWAY; MULTIPLE-MYELOMA; TRANSCRIPTION FACTORS; KINASE TAK1; IN-VIVO; NOTCH1; GENE; MUTATIONS; LYMPHOMA;
D O I
10.1016/j.ccr.2010.08.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
It was previously shown that the NF-kappa B pathway is downstream of oncogenic Notch1 in T cell acute lymphoblastic leukemia (T-ALL). Here, we visualize Notch-induced NF-kappa B activation using both human T-ALL cell lines and animal models. We demonstrate that Hes1, a canonical Notch target and transcriptional repressor, is responsible for sustaining IKK activation in T-ALL. Hes1 exerts its effects by repressing the deubiquitinase CYLD, a negative IKK complex regulator. CYLD expression was found to be significantly suppressed in primary T-ALL. Finally, we demonstrate that IKK inhibition is a promising option for the targeted therapy of T-ALL as specific suppression of IKK expression and function affected both the survival of human T-ALL cells and the maintenance of the disease in vivo.
引用
收藏
页码:268 / 281
页数:14
相关论文
共 52 条
[1]   Constitutive pre-TCR signaling promotes differentiation through Ca2+ mobilization and activation of NF-κB and NFAT [J].
Aifantis, I ;
Gounari, F ;
Scorrano, L ;
Borowski, C ;
von Boehmer, H .
NATURE IMMUNOLOGY, 2001, 2 (05) :403-409
[2]   Molecular pathogenesis of T-cell leukaemia and lymphoma [J].
Aifantis, Iannis ;
Raetz, Elizabeth ;
Buonamici, Silvia .
NATURE REVIEWS IMMUNOLOGY, 2008, 8 (05) :380-390
[3]   Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma [J].
Annunziata, Christina M. ;
Davis, R. Eric ;
Demchenko, Yulia ;
Bellamy, William ;
Gabrea, Ana ;
Zhan, Fenghuang ;
Lenz, Georg ;
Hanamura, Ichiro ;
Wright, George ;
Xiao, Wenming ;
Dave, Sandeep ;
Hurt, Elaine M. ;
Tan, Bruce ;
Zhao, Hong ;
Stephens, Owen ;
Santra, Madhumita ;
Williams, David R. ;
Dang, Lenny ;
Barlogie, Bart ;
Shaughnessy, John D., Jr. ;
Kuehl, W. Michael ;
Staudt, Louis M. .
CANCER CELL, 2007, 12 (02) :115-130
[4]  
ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369
[5]   Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 [J].
Barbie, David A. ;
Tamayo, Pablo ;
Boehm, Jesse S. ;
Kim, So Young ;
Moody, Susan E. ;
Dunn, Ian F. ;
Schinzel, Anna C. ;
Sandy, Peter ;
Meylan, Etienne ;
Scholl, Claudia ;
Froehling, Stefan ;
Chan, Edmond M. ;
Sos, Martin L. ;
Michel, Kathrin ;
Mermel, Craig ;
Silver, Serena J. ;
Weir, Barbara A. ;
Reiling, Jan H. ;
Sheng, Qing ;
Gupta, Piyush B. ;
Wadlow, Raymond C. ;
Le, Hanh ;
Hoersch, Sebastian ;
Wittner, Ben S. ;
Ramaswamy, Sridhar ;
Livingston, David M. ;
Sabatini, David M. ;
Meyerson, Matthew ;
Thomas, Roman K. ;
Lander, Eric S. ;
Mesirov, Jill P. ;
Root, David E. ;
Gilliland, D. Gary ;
Jacks, Tyler ;
Hahn, William C. .
NATURE, 2009, 462 (7269) :108-U122
[6]   Notch1 and Notch2 inhibit myeloid differentiation in response to different cytokines [J].
Bigas, A ;
Martin, DIK ;
Milner, LA .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (04) :2324-2333
[7]   Identification of the familial cylindromatosis tumour-suppressor gene [J].
Bignell, GR ;
Warren, W ;
Seal, S ;
Takahashi, M ;
Rapley, E ;
Barfoot, R ;
Green, H ;
Brown, C ;
Biggs, PJ ;
Lakhani, SR ;
Jones, C ;
Hansen, J ;
Blair, E ;
Hofmann, B ;
Siebert, R ;
Turner, G ;
Evans, DG ;
Schrander-Stumpel, C ;
Beemer, FA ;
van den Ouweland, A ;
Halley, D ;
Delpech, B ;
Cleveland, MG ;
Leigh, I ;
Leisti, J ;
Rasmussen, S ;
Wallace, MR ;
Fenske, C ;
Banerjee, P ;
Oiso, N ;
Chaggar, R ;
Merrett, S ;
Leonard, N ;
Huber, M ;
Hohl, D ;
Chapman, P ;
Burn, J ;
Swift, S ;
Smith, A ;
Ashworth, A ;
Stratton, MR .
NATURE GENETICS, 2000, 25 (02) :160-165
[8]   Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB [J].
Brummelkamp, TR ;
Nijman, SMB ;
Dirac, AMG ;
Bernards, R .
NATURE, 2003, 424 (6950) :797-801
[9]   CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia [J].
Buonamici, Silvia ;
Trimarchi, Thomas ;
Ruocco, Maria Grazia ;
Reavie, Linsey ;
Cathelin, Severine ;
Mar, Brenton G. ;
Klinakis, Apostolos ;
Lukyanov, Yevgeniy ;
Tseng, Jen-Chieh ;
Sen, Filiz ;
Gehrie, Eric ;
Li, Mengling ;
Newcomb, Elizabeth ;
Zavadil, Jiri ;
Meruelo, Daniel ;
Lipp, Martin ;
Ibrahim, Sherif ;
Efstratiadis, Argiris ;
Zagzag, David ;
Bromberg, Jonathan S. ;
Dustin, Michael L. ;
Aifantis, Iannis .
NATURE, 2009, 459 (7249) :1000-U129
[10]  
Castella P, 1999, J NEUROSCI RES, V56, P229, DOI 10.1002/(SICI)1097-4547(19990501)56:3<229::AID-JNR2>3.0.CO